[Metabolism of HB 419 in animals].
作者信息
Heptner W, Kellner H M, Christ O, Weihrauch D
出版信息
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1400-4.
PMID:5394460
Abstract
摘要
相似文献
1
[Metabolism of HB 419 in animals].[HB 419在动物体内的代谢]
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1400-4.
2
[Resorption, excretion and metabolism after intravenous and oral administration of HB 419-14C in man].[人体静脉注射和口服HB 419-14C后的吸收、排泄与代谢]
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1428-34.
3
[Resorption, distribution and excretion after administration of 14C-labelled HB 419 in rabbits, rats and dogs].[14C标记的HB 419在兔、大鼠和犬体内的吸收、分布及排泄]
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1388+.
4
[Pharmacokinetics of a new highly effective hypoglycemic sulfonylurea derivative].
Acta Diabetol Lat. 1969 Sep;6 Suppl 1:105-15.
5
[Glucose and HB 419-concentration in blood as well as HB 419-excretion in urine after single oral application of HB 419-14C].单次口服HB 419-14C后血液中葡萄糖和HB 419的浓度以及尿液中HB 419的排泄情况
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1422-8.
6
[Pharmacology of HB 419, a new strongly effective oral antidiabetic].
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1363-8.
7
[Pharmacokinetic studies with the new antidiabetic HB 419 in animals].新型抗糖尿病药物HB 419在动物体内的药代动力学研究
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1386-8.
8
[Clinico-pharmacological studies on the blood sugar reducing effect of HB 419 in healthy people].[HB 419对健康人降血糖作用的临床药理学研究]
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1421-2.
9
[Observations on the mechanism of action of the hypoglycemic effective sulfonylurea preparation HB 419].[关于降血糖有效磺酰脲制剂 HB 419 作用机制的观察]
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1472-6.
10
[Effect of tolbutamide and HB 419 on blood glucose, plasma-corticosterone and liver glycogen in rats].[甲苯磺丁脲和HB 419对大鼠血糖、血浆皮质酮及肝糖原的影响]
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1483-7.
引用本文的文献
1
Eukaliuric diuresis and natriuresis in response to the KATP channel blocker U37883A: micropuncture studies on the tubular site of action.钾离子通道阻滞剂U37883A引发的真利尿素利尿和利钠作用：肾小管作用部位的微穿刺研究
Br J Pharmacol. 1999 Aug;127(8):1811-8. doi: 10.1038/sj.bjp.0702742.
2
ATP-sensitive K+ channels in the kidney.肾脏中的ATP敏感性钾通道。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):213-25. doi: 10.1007/BF00171051.
3
[Blood sugar depression effects of hydroxytolbutamide in man].
Klin Wochenschr. 1970 Jun 15;48(12):759-60. doi: 10.1007/BF01497136.
4
Glibenclamide: a review.
Drugs. 1971;1(2):116-40. doi: 10.2165/00003495-197101020-00002.
5
Pharmacokinetics of glipizide in man: influence of renal insufficiency.
Diabetologia. 1973 Sep:331-8. doi: 10.1007/BF01218443.
6
The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.胰岛β细胞对胰岛素促分泌剂的识别。IV. 胰岛对磺脲类药物的摄取。
Diabetologia. 1973 Jun;9(3):210-6. doi: 10.1007/BF01219785.
7
The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics.西咪替丁和雷尼替丁对格列本脲药代动力学和药效学的矛盾效应。
Br J Clin Pharmacol. 1987 Jun;23(6):743-51. doi: 10.1111/j.1365-2125.1987.tb03110.x.
8
Comparison of the pharmacokinetics of glipizide and glibenclamide in man.格列吡嗪与人格列本脲的药代动力学比较。
Eur J Clin Pharmacol. 1975;8(1):63-9. doi: 10.1007/BF00616416.
Zotero 插件